AIM
XENT

Aigen Investment Management’s Intersect ENT, Inc XENT Stock Holding History

Aigen Investment Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-12,724
Closed -$208K – 1177
2020
Q3 		$208K Sell
12,724
-37,421
-75% -$678K 0.03% 638
2020
Q2 		$679K Buy
50,145
+14,707
+42% +$171K 0.09% 366
2020
Q1 		$420K Buy
35,438
+5,076
+17% +$113K 0.06% 487
2019
Q4 		$756K Buy
+30,362
New +$615K 0.13% 236

Other funds holding XENT

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Aigen Investment Management's XENT Position: Q4 2020 in Review

Aigen Investment Management sold out of Intersect ENT, Inc (XENT) in Q4 2020, closing a stake of 12,724 shares — an estimated $208K sold.

Aigen Investment Management first reported a position in XENT in Q4 2019 and held it in 4 quarters. The position peaked at $756K in Q4 2019. 110 funds tracked by Wall St. Rank hold XENT as of Q4 2020.

  • Aigen Investment Management reported no remaining Intersect ENT, Inc position as of Q4 2020 after selling out during the quarter.
  • Aigen Investment Management sold 12,724 Intersect ENT, Inc shares in Q4 2020, an estimated $208K.
  • Aigen Investment Management first reported a position in Intersect ENT, Inc in Q4 2019 and held it in 4 quarters.
  • Aigen Investment Management's Intersect ENT, Inc position peaked at $756K in Q4 2019.
  • 110 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2020.

Based on Aigen Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.